Board Expansion Recent additions to AVNA's Board of Directors including David Bonvenuto and Aaron Mambrino signal strategic governance and potential to unlock new partnerships and funding avenues, suggesting opportunities to approach leadership for long-term contracts and collaboration.

Innovation Awards Costa Rica plant received the Excellence in Innovation and Technology Award for titanium micro-implants used in oncology, highlighting strength in advanced materials and regulated medical manufacturing—a strong lead for targeting oncology device OEMs and institutions requiring high-precision implants.

R&D Access NextTech R&D & Prototype Centers enable co-development and rapid testing with AVNA engineers, presenting a sales angle around early-stage collaborative programs and manufacturability optimization for new medical devices seeking speed to market.

Capabilities Match Full-spectrum in-house capabilities across metal forming, multi-axis CNC and laser machining, plastic injection and over-molding, micro-machining, stamping, and automated assemblies align with OEM needs for complex, high-precision components and integrated sub-assemblies.

Quality & Traceability Integrated quality systems with real-time data, metrology, and ISO13485 alignment offer compelling value for regulated medical devices requiring stringent traceability, enabling sales pitches focused on compliance, risk mitigation, and reliable supplier performance.